One of the major limitations on the overall management of lung cancer is that we lack a proven strategy for early detection. Our goal is to use biomarkers predictive of cancer development to detect lung cancer early while cure remains possible. The central hypothesis of this proposal is that the bronchial epithelium acquires molecular abnormalities before the invasive stage and that specific genes and proteins may be used as biomarkers for early detection of lung cancer. To test this hypothesis, we propose the following aims:
Specific Aim 1. To identify new molecular abnormalities specific to the development of squamous carcinoma of the lung. We propose to take a combined genetic and proteomic approach to discover the determinants of squamous carcinoma development. From these studies in normal bronchial epithelium, preinvasive and invasive lesions using high-density genomic array, matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and custom oligonucleotide array, we will carefully select candidate biomarkers to be tested in Aim 2.
Specific Aim 2. To determine the prevalence of candidate biomarkers in lung cancer progression and to calculate the odds of developing lung cancer according to biomarkers status in preinvasive lesions. FISH and IHC applied to tissue micro array sections enable high throughput analysis of molecular alterations that may contribute to cancer development and progression.
Specific Aim 3. To determine the odds of developing lung cancer according to proteomic biomarker status in the normal bronchial epithelium of high-risk individuals. We will test those in a unique set of bronchial specimens obtained prospectively in a cohort of high-risk individuals, some of whom developed lung cancer. In summary, we are proposing to interrogate the human squamous tumorigenesis model by genetic and protein approaches, identify candidate genes involved in tumorigenesis and test their potential role as biomarkers predictive of lung cancer development. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA102353-04
Application #
7369709
Study Section
Special Emphasis Panel (ZRG1-CBSS (01))
Program Officer
Krueger, Karl E
Project Start
2005-03-01
Project End
2010-02-28
Budget Start
2008-03-13
Budget End
2010-02-28
Support Year
4
Fiscal Year
2008
Total Cost
$232,876
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Ji, Xiangming; Qian, Jun; Rahman, S M Jamshedur et al. (2018) xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 37:5007-5019
Codreanu, Simona G; Hoeksema, Megan D; Slebos, Robbert J C et al. (2017) Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma. J Proteome Res 16:3266-3276
Qian, Jun; Chen, Heidi; Ji, Xiangming et al. (2017) A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy. Sci Rep 7:45828
Rahman, S M Jamshedur; Ji, Xiangming; Zimmerman, Lisa J et al. (2016) The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight 1:e88814
Boutaud, Olivier; Sosa, I Romina; Amin, Taneem et al. (2016) Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prev Res (Phila) 9:855-865
Hassanein, Mohamed; Hight, Matthew R; Buck, Jason R et al. (2016) Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer. Mol Imaging Biol 18:18-23
Hassanein, Mohamed; Qian, Jun; Hoeksema, Megan D et al. (2015) Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int J Cancer 137:1587-97
Qian, Jun; Hassanein, Mohamed; Hoeksema, Megan D et al. (2015) The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers. Proc Natl Acad Sci U S A 112:3469-74
Sekhar, Konjeti R; Benamar, Mouadh; Venkateswaran, Amudhan et al. (2014) Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. Int J Radiat Oncol Biol Phys 89:1106-1114
Harris, Fredrick T; Rahman, S M Jamshedur; Hassanein, Mohamed et al. (2014) Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer. Cancer Prev Res (Phila) 7:748-57

Showing the most recent 10 out of 30 publications